Editorial board

Kevin Keane, DVM, PhD, FIATP Blueprint Medicines, Cambridge, MA, USA

Rani S. Sellers, DVM, PhD School of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA

Tom Green J&J Editorial, Cary, NC, USA

Beth Mahler Experimental Pathology Labs, NC, USA

Ronnie Chamanza, BVSc, MSc, FRC Path, MRCVS, FIATP Johnson & Johnson, Beerse, Belgium
Sundeep Chandra, BVSc, PhD, DACVPBVSc, DACVP Biomarin, San Rafael, CA, USA
Jeff Everitt, DVM Duke University School of Medicine, USA
Beatrice Gauthier, DVM Sanofi-Aventis Recherche et Developpement, Montpellier, France
Peter Hall, BVetMed, MRCVS, PhD, FRCPath UCB Pharma Ltd., Berkshire, UK
Renee Hukkanen, DVM, MS, DACVP Amgen, Cambridge, MA, USA
Ramesh Kovi, BVSc & AH, MVSc, PhD, DACVP, DABT, FIATP AstraZeneca
Sean Troth, DVM, PhD, DACVP Merck & Co., Inc.

Brad Bolon, DVM, MS, PhD, DACVP, DABT, FATS, FIATP, FRCPath GEMpath, Inc., Longmont, CO, USA
Susan A. Elmore, MS, DVM, DACVP, DABT, FIATP Elmore Pathology, Chapel Hill, NC,USA
Abraham Nyska, DVM, PhD, FIATP Sackler School of Medicine, Tel Aviv University, Timrat, Israel
Jerrold M. Ward, DVM, PhD, FIATP Global Vet Pathology, USA

Tracy Carlson, BS, DVM, PhD, DACVP Charles River, Mattawan, MI
Elizabeth McInnes, BVSc, PhD, FRCPath, MRCVS, FIATP Syngenta, Berks, UK
Erin Quist, DVM, MS, PhD, DACVP EPL Inc, Research Triangle Park, NC, USA

Mark Hoenerhoff, DVM, PhD, DACVP, FIATP University of Michigan Medical School, Ann Arbor, MI, USA

Mallikarjun Bidarimath  

Rachael Wolters  

Ute Bach, DVM Bayer AG Wuppertal, Germany
Dinesh Bangari, BVSc, MVSc, MS, PhD, DACVP Sanofi, Framingham, MA USA
Duane Belote, DVM, DACVP Covance Laboratories Inc., Chantilly, VA, USA
Lise Bertrand, DVM, MSc, DESV pathology Dipl ECVP Charles River Laboratories Lyon, France
Brad Blakenship, DVM, DACVP Charles River Laboratories, Reno, NV, USA
Rogely Boyce, DVM, PhD, DACVP Beechy Ridge ToxPath LLC, Clay, WV, USA
Cory Brayton, DVM, ACLAM, DACVP Johns Hopkins University School of Medicine, Baltimore, MD, USA
Danielle Brown, DVM, MS, DACVP, FIATP Charles River Laboratories, Durham, NC, USA
Erica Eggers Carroll, DVM, PhD, DACVP, DABT Labcorp, Greenfield, IN, USA
Russ Cattley, VMD, PhD, FIATP Auburn University, Auburn, AL, USA
Ronnie Chamanza, BVSc, MSc, FRC Path, MRCVS, FIATP Johnson & Johnson, Beerse, Belgium
Franck Chanut, DVM, MSc, DECVP, DESV-AP Sanofi, Paris, France
Shambhunath Choudhary, BVSc, PhD, DACVP Pfizer, USA
Mark Cline, DVM, PhD, DACVP, FIATP Wake Forest School of Medicine, Winston-Salem, NC, USA
Samuel M. Cohen, MD, PhD, FIATP University of Nebraska Medical Center, Omaha, NE, USA
Kevin Donnelly, DVM, PhD Theravance Inc., San Francisco, CA, USA
Michael R. Elwell, DVM, PhD, FIATP Apex ToxPath, Apex, NC, USA
Jurgen Funk, Dr. Med. Vet. Hoffman-LaRoche, Basel, Switzerland
Kathleen A. Funk, DVM, PhD, DACVP Experimental Pathology Laboratories Inc., Sterling, VA, USA
Santokh Gill, PhD Health Canada, Ottawa, Canada
Adam Hargreaves, FRCPath, DACVP PathCelerate Ltd., Cheshire, UK
Johannes Harleman, DVM, PhD, ERT, FIATP Global Preclinical Development & Management GMCRA, Darmstadt, Germany
Wanda M. Haschek-Hock, BVSc, PhD, DACVP, DABT, FIATP University of Illinois, Urbana, IL, USA
Paul Howroyd, FRCPath Charles River Laboratories, Tranent, UK
Armando Irizarry, DVM, PhD, DACVP Eli Lilly & Company, Indianapolis, IN, USA
Kyathanahalli Janardhan, BVSc, MVSc, PhD, DACVP Abbvie, North Chicago, IL, USA
Takahito Kambara, BVSc, MVSc, PhD, FRCPath AbbVie Inc., North Chicago, IL, USA
Timothy LaBranche, DVM PhD DACVP Blueprint Medicines, Cambridge, MA, USA
Michela Levi, DVM PhD DECVP MRCVS Labcorp Early Development Laboratories Limited, UK
Heike Antje Marxfeld, PhD, DiplECVP, EBVS BASF, Ludwigshafen, Germany
Sandra McBride, PhD Social & Scientific Systems, Durham, NC, USA
Elizabeth McInnes, BVSc, PhD, FRCPath, MRCVS, FIATP Syngenta, Berks, UK
Mark Mense, DVM, PhD, MBA, DACVP, DABT, PMP, FIATP Labcorp Drug Development, Chantilly, VA, USA
James Morrison, DVM, DACVP Charles River Laboratories Pathology, Durham, NC, USA
Leslie Ann Obert, DVM, PhD, DACVP GlaxoSmithKline, Collegeville, PA, USA
Ricardo Ochoa, DVM, PhD, DACVP, FIATP Pre-Clinical Safety Inc., Niantic, CT, USA
Arun Pandiri, BVSc&AH, MS, PhD, DACVP Experimental Pathology Laboratories, Research Triangle Park, NC, USA
Giovanni Pellegrini, DVM, PhD, DECVP AstraZeneca, Gothenburg, Sweden
Erin M. Quist, DVM, MS, PhD, DACVP Experimental Pathology Laboratories, Research Triangle Park, NC, USA
Zaher A. Radi, DVM, MBA, PhD, DABT, DACVP Pfizer, Cambridge, MA, USA
Deepa Rao, BVSc, MS, PhD, DABT, DACVP, FIATP Greenfield Pathology Services, Inc., Greenfield, IN, USA
Jerry Rehg, DVM St. Jude Children's Research Hospital, Memphis, TN, USA
Amera K. Remick, DVM, DACVP, DABT Charles River Laboratories, Durham, NC, USA
Matthias Rinke, DVM, FIATP Wuelfrath, Germany
Susanne Rittinghausen, DVM, Dr. Med. Vet. Habil. Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany
Catherine L Ross DVM MSc(VetPath) MSc(ApplTox) MRCVS Covance Laboratories Limited, North Yorkshire, United Kingdom
Melissa M. Schutten, DVM, PhD, DACVP Ultragenyx Pharmaceuticals, Novato, CA USA
Cheryl Scudamore, BVSc, PhD, MRCVS, FHEA, FRCPath ExePathology, Devon, UK
Keith R. Shockley, PhD NIEHS/NIH, Research Triangle Park, NC, USA
Kanaka Tatikola, MS Johnson & Johnson, Bridgewater, NJ, USA
Reginald A. Valdez, DVM, MS, PhD, DACVP Amgen, Cambridge, MA, USA
Justin Vidal, DVM, PhD Charles River Laboratories Inc, Mattawa, MI, USA
Jonathan Werner, DVM, PhD, DACVP Amgen, Thousand Oaks, CA
Matthew Wheeler, PhD CDC/NIOSH, Cincinnati, OH, USA
Cynthia J. Willson, MS, PhD, DVM, DACVP Integrated Laboratory Systems, Research Triangle Park, NC, USA
Zbigniew W. Wojcinski, DVM, DVSc, DACVP, DABT, FIATP Toxicology & Pathology Consulting, LLC, Hillsborough, NC USA
Jeff Wolf, DVM, DACVP Experimental Pathology Laboratories Inc., Sterling, VA, USA
Charles Wood, DVM, PhD, DACVP Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA